Skip to main content

Table 2 Characteristics and results of the selected experimental models of systemic sclerosis

From: Dualities of the vitamin D in systemic sclerosis: a systematic literature review

Author

Year

Research Design

Main results

Slominski et al. [44]

2013

Culture of skin fibroblasts from patients and controls

Efficacy of vitamin D in inhibiting TGF-induced collagen synthesis and inhibiting cell proliferation in fibroblasts from patients and controls; vitamin D suppressed fibrogenesis in a bleomycin-induced sclerosis model.

Terao et al. [45]

2015

Experimental model

Effect of vitamin D analogue on periostin expression in fibroblasts and bleomycin-induced sclerosis model; maxacalcitol reduces the expression of periostin and TGF-β and suppresses the Th2 response.

Usategui et al. [46]

2014

Cutaneous fibrosis in animal model

Effect of the topical analogue of vitamin D (calcipotriol) on cytokines and the development of fibrosis in rats with bleomycin-induced sclerosis; calcipotriol overexpressed Th2 axis expression, with antifibrotic effect.

Zerr et al. [47]

2014

Culture of skin fibroblasts from patients and controls

Expression of VDR in experimental model and fibroblasts; effect of paricalcitol on bleomycin-induced fibrosis model and overexpression of TGF-β receptor (TBRICA); VDR characterization as a negative regulator of TGF-β / Smad pathway signaling.

  1. Abbreviations: TGF-β transforming growth factor β, VDR Vitamin D receptor